About the journal
NeuroMolecular Medicine is a journal published by Springer Science+Business Media in United States. It is listed in MEDLINE according to the sources read. Declared publication charge: 4,490 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Springer Science+Business Media
- ISSN
- 1559-1174 · 1535-1084
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 4,490 EUR
- Declared peer-review model
- peer_review
- Official website
- https://www.springer.com/journal/12017
Index listings
- MEDLINE · 2002-01-01
- Indexing
- MEDLINE
- APC
- 4,490 EUR
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 70 days received→accepted — computed from PubMed (n=98)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1130
Last recorded publication year
2026
h-index
100
i10-index
785
From OpenAlex open data (CC0).
Editorial & policy6
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 25%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Neuromol. med.Neuromolecular MedNMM
- Source type
- journal
- NLM unique ID (PubMed)
- 101135365
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Neuroinflammation and Neurodegeneration Mechanisms
- Neuroinflammation and Neurodegeneration Mechanisms
- Alzheimer's disease research and treatments
- Alzheimer's disease research and treatments
- Mitochondrial Function and Pathology
- Mitochondrial Function and Pathology
- Neuroscience and Neuropharmacology Research
- Neuroscience and Neuropharmacology Research
Show all subjects (50)
- Parkinson's Disease Mechanisms and Treatments
- Parkinson's Disease Mechanisms and Treatments
- Neurogenesis and neuroplasticity mechanisms
- Nerve injury and regeneration
- MicroRNA in disease regulation
- Nerve injury and regeneration
- MicroRNA in disease regulation
- Neurogenesis and neuroplasticity mechanisms
- Genetic Neurodegenerative Diseases
- Genetic Neurodegenerative Diseases
- Genetics and Neurodevelopmental Disorders
- Genetics and Neurodevelopmental Disorders
- Hereditary Neurological Disorders
- Hereditary Neurological Disorders
- Tryptophan and brain disorders
- Neurological Disease Mechanisms and Treatments
- Tryptophan and brain disorders
- Neurological Disease Mechanisms and Treatments
- Autophagy in Disease and Therapy
- Autophagy in Disease and Therapy
- Nuclear Receptors and Signaling
- Nuclear Receptors and Signaling
- Amyotrophic Lateral Sclerosis Research
- Amyotrophic Lateral Sclerosis Research
- Circular RNAs in diseases
- Neurological diseases and metabolism
- Circular RNAs in diseases
- Neurological diseases and metabolism
- Epigenetics and DNA Methylation
- Epigenetics and DNA Methylation
- Adipose Tissue and Metabolism
- S100 Proteins and Annexins
- Cancer-related molecular mechanisms research
- Adipose Tissue and Metabolism
- S100 Proteins and Annexins
- Cancer-related molecular mechanisms research
- RNA regulation and disease
- RNA regulation and disease
- Cellular transport and secretion
- Cellular transport and secretion
- Cholinesterase and Neurodegenerative Diseases
- Cholinesterase and Neurodegenerative Diseases
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ